



Copyright © 2011 Korean Society of Intravascular Neurosurgery
INTRODUCTION
With the advent of endovascular devices and operative 
techniques, procedure-related complications have decrea-
sed in recent years. However, one of the most common 
complications during endovascular procedures is thrombo-
embolic arterial occlusion. Ries et al. have reported a 
9.3%rate of thromboembolic events during aneurysmal coil 
embolizations (48 cases among 515 cerebral aneurysms).10) 
Aggour et al. have reported a 10% rate of thromboembolic 
events related to the procedures (39 patients among 390 
aneurysmal coiling procedures).2) These thromboembolic 
complications are closely related to permanent neurological 
deficits; therefore, early intervention and recanalization pro-
ceduresare required as soon as possible.
Conventional management of these complications in-
cludes intravenous or intra-arterial pharmacological therapy, 
including tissue plasminogen activator (t-PA), urokinase or 
glycoprotein IIb-IIIa inhibitor (Tirofiban). However, in cases 
of ruptured cerebral aneurysms, these chemical therapies 
have some limitations due to risk of rebleeding or other 
hemorrhagic complications. Recently, the effectiveness of 
self-expandable stents (SESs) has been reported in the re-
canalization of acute ischemic stroke. Brekenfeld et al. have 
managed 12 patients with intracranial SESs for acute isch-
emic stroke, resulting in partial or complete recanalization 
(thrombolysis in myocardial infarction [TIMI] 2/3) in 92% of 
the patients.4) Roth et al. have reported successful revascu-
larization with the use of SESs in 20 of 22 (90.9%) patients 
(thrombolysis in cerebral infarction [TICI] 2a/b and 3).11)
We experienced a few cases of acute thromboembolism 
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after endovascular treatment of ruptured cerebral aneu-
rysms and tried various rescue therapies, including SESs. 
We present our experience in this article.
METHODS
We retrospectively reviewed patients with ruptured cere-
bral aneurysms treated with endovascular means from 
March 2009 until February 2011 in our department. Among 
these patients, 7 developed acute thromboembolic events 
during an endovascular procedure. Two were men and the 
other 5 were women, and their mean age was 56 years. 
Among these 7 patients, 5 had middle cerebral artery 
(MCA) occlusion, 1 had internal cerebral artery (ICA) occlu-
sion and 1 had posterior cerebral artery (PCA) occlusion. 
We managed these acute arterial occlusions withchemical 
thrombolysis and/or SESs.The chemical thrombolytic 
agents we used wereurokinase and the GPIIb/IIIa receptor 
inhibitor, Tirofiban. In mechanical recanalization, we used 
Enterprise (Codman Neurovascular, Miami Lakes, FL) and 
Solitaire stents (ev3 Incorporation, Plymouth, MN) as SESs. 
Recanalization results were assessed by follow-up angiog-
raphy immediately after the procedure. We used a TICI 
grading system for scoring, and neurologic status was 
evaluated before and after rescue therapy. 
 
RESULTS
Seven patients with ruptured cerebral aneurysmstreated 
by endovascular methods had acute thromboembolic 
complications. The characteristics and clinical results of 
patients treated by rescue therapy were summarized in Ta-
ble 1. In all 7 cases, chemical thrombolysis was performed 
as a first line rescue therapy using urokinase and/or glyco-
protein IIb/IIIa inhibitors. With concerns about the risk of 
re-bleeding during the endovascular procedure, substantial 
doses of chemical agents were not feasible. Among the 7 
patients, intra-arterial thrombolysis (IAT) was successful 
only in 3, and their TICI grades were 2a (n=3). In the other 
4 patients, intracranial SESs were used in addition to 
thechemical agents. Indication for SES insertion was failed 
IAT during the rescue procedure. Three of these patients 
(75%) had near complete or complete recanalization, with 
TICI grades of 2b (n=1) or 3 (n=2). There were no device-
related complications. No vessel perforations or dissec-
tions were visible, and embolization into another vessel ter-
ritory was not detected in any cases. 
Five of 7 patients had immediate motor recovery in a 
day or two after rescue therapy and had no neurologic 
deficits at discharge. One patient had grade 3 motor weak-
ness immediatelyafter surgerybut showed motor grade 4 in 
neurologic follow-up at discharge, after rehabilitation and 
physiotherapy. Two of 7 patients had motor and/or sensory 
aphasia, but their symptoms improved at 3 months follow-
up, and they did not show any neurological deficits.
We observedone case of acute in-stent thrombosis after 
recanalization with SES. A patient with a ruptured M1 an-
eurysm had stent-assisted coil embolization, and acute 
ICA occlusion was noted in the final angiography. Enter-
prise stent insertion was performed after failed IAT, and re-
canalization of the ICA was achieved, but re-occlusion of 
the vessel was found. The patient had to undergoemer-
gency STA-MCA bypass operation.
ILLUSTRATIVE CASES
Case 1
This 57-year-old female patient presented with severe 
headache. Initial brain CT and MR imaging showed SAH 
(Fisher grade 3, Hunt and Hess score 3). CT angiography 
showed a ruptured saccular aneurysm in the basilar tip, 
also indicatedby DSA and 3D DSA. Endovascular coil oc-
clusion of the aneurysm was attempted without heparin-
ization. Withstent-assisted aneurismal coiling, the aneuris-
mal sac was successfully occluded with coils, but in-stent 
thrombosis was noted in the left PCA territory (Fig. 1A). 
Despite the use of 1.5 mg of Tirofiban, the PCA occlusion 
did not improve. Because additional use of thrombolytic 





Diagnosis Initial treatment Occlusion Rescue IAT MT Results (TICI)
1 F/55 SAH, pcom Coil embolization MCA occlusion Chemical UK 250,000 No 2a
2 M/49 SAH, acom Coil embolization MCA occlusion Chemical UK 200,000 No 2a
3 F/52 SAH, acom Coil embolization MCA occlusion Chemical Tirofiban 0.5 mg No 2a





5 F/57 SAH, BA Coil embolization PCA occlusion SES* Tirofiban 1.0 mg Enteprise stent 3
6 F/63 SAH, pcom Coil embolization MCA occlusion SES* Tirofiban 0.7 mg Enterprise stent 3
7 F/69 SAH, acom Coil embolization MCA occlusion SES* UK 200,000 Solitaire stent 2b
IAT: Intra-arterial thrombolysis, MT: Mechanical thromboembolectomy, SAH: Subarachnoid hemorrhage, Pcom: Posterior 
communicating artery, MCA: Middle cerebral artery, ICA: Internal carotid artery, STA: Superficial temporal artery, UK: Uroki-
nase, BA: Basilar apex, Acom: Anterior communicating artery, Chem: Chemical thromobolysis, SES: Self-expanding stent, 
TICI: Thrombolysis in cerebral ischemia
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agents was dangerous due to the ruptured aneurysm, we 
useda self-expendable stent for recanalization of the PCA 
occlusion. We advanced the microcatheter to the left PCA, 
and the Enterprise stent was deployed. After stenting, PCA 
flow was recovered, and full recovery of PCA flow was ob-
served in 20 minutes delayed angiography as well asin 
DSA the followingday (Fig. 1B). The patient was discharged 
without any clinical deficits.
Case 2
This 69-year-old female patient presented with aSAH 
proven by CT (Fisher grade 3, Hunt and Hess score.2) Con-
ventional angiography with 3D reconstruction showed a 
ruptured aneurysm at the anterior communication artery 
(Acom). The patient was old and had an extremely tortu-
ous aortic angle. At the beginning of emergency coil em-
bolization, we usedan Simons-2 guide catheter and ad-
vanced a 6 French envoy guiding catheter using exchange 
guide-wire. At the first angiography, acute MCA occlusion 
occurred probably because of an atheroma of the com-
mon carotid artery (Fig. 2A). Coil embolization of the rup-
tured Acom aneurysm was performed first, and rescue 
therapy for MCA occlusion was followed. Chemical recan-
alization was attempted with urokinase 200,000 units but 
failed because a significant dose could not be used due to 
risk of hemorrhage. We deployed a self-expandable Soli-
taire stent and performed mechanical thrombectomy, pull-
ing back the device in the unfolded state using an aspira-
tion technique. We identified the thrombus within the stent 
after withdrawal. In the final angiography, MCA flow 
achieved a TICI grade 2b (Fig. 2B). The patient had grade 
4 motor weakness of the contralateral extremities immedi-
ately after the procedure but showed recovery to near-nor-
mal motor grade at discharge. 
DISCUSSION
In several stroke studies, it has been documented that 
successful recanalization and good outcome after acute 
ischemic strokesarestrongly associated.3,4,9) If thromboem-
bolic complicationsoccurin hemorrhagic patients, chemical 
thrombolysis can yield fatal outcomescompared to cases 
Figure 1. Digital subtraction angiogram shows acute PCA occlusion (A). The control angiogram after rescue therapy with Tirofiban 
and Enterprise stent shows recanalized vessel (B). 
A B
Figure 2. Acute M1 occlusion (A). After mechanical thrombectomy with Solitaire stent and chemical thrombolysis, the vessel is re-
vascularized to a TICI 2b state (B). 
A B
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of non-hemorrhagic patients. Because every patient in this 
study had a ruptured aneurysm and SAH, recanalization of 
occluded cerebral arteries was more challenging than in 
the setting of acute ischemic stroke.
We used intra-arterial chemical thrombolysis,which 
means intra-arterial bolus infusion of drugs proximal to the 
occluded vessel directly,as a first line rescue therapy. How-
ever, we could not use high doses of chemical agents be-
cause all of our patients had SAH. The use of pharmaco-
logic thrombolysis alone has many concerns: increased 
risk of bleeding, doubts about the effectiveness of dissolv-
ing clots, lengthy times to recanalization, and inability to 
prevent abrupt re-occlusion at the initial site of obstruc-
tion.6,8) Despite increasing utilization of prourokinase or 
other antithrombotic agents (e.g., alteplase and reteplase), 
recanalization rates remain approximately 60% in acute 
ischemic stroke.6,8) Not surprisingly, a combination of me-
chanical and pharmacologic approaches would yield 
greater benefit in such situations.8)
The use of other mechanical means has been reported 
to be effective in recanalization of acute occlusions.8) Me-
chanical thrombectomy techniques are reported in cases 
of failed recanalization after thrombolysis or in patients with 
contraindications to thrombolytic agents.1,11) In recent stud-
ies, intracranial stent placement has been performed for 
recanalization of cerebral arterial occlusion in acute stroke 
patients.5,7,11) Researchershave reported favorable out-
comes with the use of SESs, with recanalization rates of 
79% to 100%.4,11,13) SESs apply a lower radial force than 
does the inflation of balloon-mounted stents, reducing the 
risk of vessel rupture in cases of hard thrombus or athero-
sclerotic stenosis.4) In the latest studies, mechanical throm-
bectomy with an unfolded, fully retrievable SES yielded 
very promising angiographic and clinical results.11) In one 
patient, we deployed and withdrew an unfolded Solitaire 
stent with constant aspiration, performed mechanical 
thrombectomy, and achieved a TICI grade 2b immediately 
after the rescue procedure. In recent papers regardin-
gacute ischemic stroke, application of SESs has been re-
ported to produce immediate recanalization and has a very 
high success rate.2,4,8,12)
We immediately used aspirin after stent placement, fol-
lowed by a combination therapy of aspirin and clopidogrel 
for the next 4 weeks, despite the presence of SAH. Be-
cause the ruptured aneurysm was packed with detachable 
coils, we used double medications to avert stent occlusion 
and further thrombo-embolism. 
There was no spontaneous intracerebralhemorrahge or 
SAH related to the procedure in our study. None of the pa-
tients died or had severe neurologic deficits. There are 
some limitations in our study. It was a retrospective, single 
center-study that hada very small number of patients. 
Also,various different modalities have been used in rescue 
therapy, so the interpretation of results should be analyzed 
with caution.
CONCLUSIONS
With use of various endovascularrescue techniques, we 
can minimize the occurrence of permanent neurological 
deficits from thromboembolic complications during endo-
vascular procedures. Stent-assisted revascularization with 
concomitant administration of IIb-IIIainhibitors contributed 
to the achievement of increased recanalization rates. 
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